REG - Assura plc - Notice of Results

AssuraAnnouncement

22/04/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210422:nRSV2337Wa&default-theme=true

RNS Number : 2337W  Assura PLC  22 April 2021

22 April 2021

Assura plc

Notice of Annual Results

Assura plc ("the Company"), the UK's leading primary care property investor
and developer can confirm that Annual Results for the year ended 31 March 2021
will be announced on Tuesday 18(th) May 2021.

A presentation for analysts will be held on that date at 8.00am BST and
details of how to watch this event can be found on our website, or by using
the link below.

Webcast link:
 https://webcasting.brrmedia.co.uk/broadcast/6075561c0386285386cc7bef
(https://protect-eu.mimecast.com/s/8HamCwmJVC92Y3fqAgNy)

- Ends -

 

For more information, please contact:

 Assura plc                                  Tel: 01925 420680
 David Purcell, Head of Investor Relations   Email: Investor@assura.co.uk
 Finsbury                                    Tel: 0207 251 3801

                                           Email: Assura@Finsbury.com
 Gordon Simpson

James Thompson

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT
and long-term investor in and developer of primary care property. The company,
headquartered in Warrington, works with GPs, health professionals and the NHS
to create outstanding spaces for health services in our communities. At 30
September 2020, Assura's property portfolio was valued at £2,259 million.

 

Further information is available at www.assuraplc.com
(http://www.assuraplc.com)

 

*EPRA is a registered trademark of the European Public Real Estate
Association.

 

Assura plc LEI code: 21380026T19N2Y52XF72

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORMZGZDGMDGMZZ